evidence human transmission amyloid-beta pathology cerebral amyloid angiopathy 
two hundred individuals developed creutzfeldt-jakob disease cjd worldwide result treatment typically childhood human cadaveric pituitary-derived growth hormone contaminated prions12 although treatment ceased iatrogenic cjd icjd continues emerge prolonged incubation periods seen human prion infections unexpectedly autopsy study eight individuals icjd aged - years four found moderate severe grey matter vascular amyloid-beta beta pathology beta deposition grey matter typical seen alzheimers disease beta blood vessel walls characteristic cerebral amyloid angiopathy3 co-localize prion protein deposition none patients pathogenic mutations apoe epsilon high-risk alleles4 associated early-onset alzheimers disease examination series patients prion diseases prospective observational cohort study5 showed minimal beta pathology cases similar age range decade older without apoe epsilon risk alleles also analysed pituitary glands individuals beta pathology found marked beta deposition multiple cases experimental seeding beta pathology previously demonstrated primates transgenic mice central nervous system peripheral inoculation alzheimers disease brain homogenate6- marked deposition parenchymal vascular beta relatively young patients icjd contrast prion disease patients population controls consistent iatrogenic transmission beta pathology addition cjd suggests healthy exposed individuals may also risk iatrogenic alzheimers disease cerebral amyloid angiopathy findings also prompt investigation whether known iatrogenic routes prion transmission may also relevant beta proteopathic seeds associated neurodegenerative human diseases 
